These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 28591212)

  • 21. Association of the von Willebrand Factor-ADAMTS13 Ratio With Incident Cardiovascular Events in Patients With Peripheral Arterial Disease.
    Green D; Tian L; Greenland P; Liu K; Kibbe M; Tracy R; Shah S; Wilkins JT; Huffman MD; Liao Y; Lloyd Jones D; McDermott MM
    Clin Appl Thromb Hemost; 2017 Oct; 23(7):807-813. PubMed ID: 27317583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Balance between von Willebrand factor and ADAMTS13 following major partial hepatectomy.
    Groeneveld DJ; Alkozai EM; Adelmeijer J; Porte RJ; Lisman T
    Br J Surg; 2016 May; 103(6):735-743. PubMed ID: 27005894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. von Willebrand Factor, ADAMTS13 Activity, and Decline in Kidney Function: A Population-Based Cohort Study.
    Sedaghat S; de Vries PS; Boender J; Sonneveld MA; Hoorn EJ; Hofman A; de Maat MP; Franco OH; Ikram MA; Leebeek FW; Dehghan A
    Am J Kidney Dis; 2016 Nov; 68(5):726-732. PubMed ID: 27497525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Von Willebrand factor, ADAMTS13 and mortality in dialysis patients.
    Ocak G; Roest M; Verhaar MC; Rookmaaker MB; Blankestijn PJ; Bos WJW; Fijnheer R; Péquériaux NC; Dekker FW
    BMC Nephrol; 2021 Jun; 22(1):222. PubMed ID: 34134634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ratio of von Willebrand factor propeptide to ADAMTS13 is associated with severity of sepsis.
    Fukushima H; Nishio K; Asai H; Watanabe T; Seki T; Matsui H; Sugimoto M; Matsumoto M; Fujimura Y; Okuchi K
    Shock; 2013 May; 39(5):409-14. PubMed ID: 23481506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma ADAMTS13 activity and von Willebrand factor antigen and activity in patients with subarachnoid haemorrhage.
    Kumar M; Cao W; McDaniel JK; Pham HP; Raju D; Nawalinski K; Frangos S; Kung D; Zager E; Kasner SE; Levine JM; Zheng XL
    Thromb Haemost; 2017 Apr; 117(4):691-699. PubMed ID: 28102428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Von Willebrand Factor Adhesive Activity and ADAMTS13 Protease Activity in HIV-1-Infected Men.
    Graham SM; Chen J; Le J; Ling M; Chung DW; Liles WC; López JA
    Int J Med Sci; 2019; 16(2):276-284. PubMed ID: 30745808
    [No Abstract]   [Full Text] [Related]  

  • 28. ADAMTS-13-VWF axis in sickle cell disease patients.
    Ladeira VS; Barbosa AR; Oliveira MM; Ferreira LGR; de Oliveira Júnior WV; de Oliveira Renó C; Reis EA; Chaves DG; Dusse LMS; Dos Santos HL; de Barros Pinheiro M; Rios DRA
    Ann Hematol; 2021 Feb; 100(2):375-382. PubMed ID: 33404693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High VWF, low ADAMTS13, and oral contraceptives increase the risk of ischemic stroke and myocardial infarction in young women.
    Andersson HM; Siegerink B; Luken BM; Crawley JT; Algra A; Lane DA; Rosendaal FR
    Blood; 2012 Feb; 119(6):1555-60. PubMed ID: 22110247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Associations between the von Willebrand Factor-ADAMTS13 Axis, Complement Activation, and COVID-19 Severity and Mortality.
    Sinkovits G; Réti M; Müller V; Iványi Z; Gál J; Gopcsa L; Reményi P; Szathmáry B; Lakatos B; Szlávik J; Bobek I; Prohászka ZZ; Förhécz Z; Mező B; Csuka D; Hurler L; Kajdácsi E; Cervenak L; Kiszel P; Masszi T; Vályi-Nagy I; Prohászka Z
    Thromb Haemost; 2022 Feb; 122(2):240-256. PubMed ID: 35062036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. VWF/ADAMTS13 Imbalance, But Not Global Coagulation or Fibrinolysis, Is Associated With Outcome and Bleeding in Acute Liver Failure.
    Driever EG; Stravitz RT; Zhang J; Adelmeijer J; Durkalski V; Lee WM; Lisman T
    Hepatology; 2021 May; 73(5):1882-1891. PubMed ID: 32767567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of plasma von Willebrand factor-cleaving protease (ADAMTS13) antigen levels in patients with coronary artery disease.
    Miura M; Kaikita K; Matsukawa M; Soejima K; Fuchigami S; Miyazaki Y; Ono T; Uemura T; Tsujita K; Hokimoto S; Sumida H; Sugiyama S; Matsui K; Yamabe H; Ogawa H
    Thromb Haemost; 2010 Mar; 103(3):623-9. PubMed ID: 20135067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of plasma von Willebrand factor and its cleaving protease ADAMTS13 in patients with atrial fibrillation.
    Freynhofer MK; Gruber SC; Bruno V; Höchtl T; Farhan S; Zaller V; Wojta J; Huber K
    Int J Cardiol; 2013 Sep; 168(1):317-25. PubMed ID: 23041092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Traumatic injury results in prolonged circulation of ultralarge von Willebrand factor and a reduction in ADAMTS13 activity.
    Dyer MR; Plautz WE; Ragni MV; Alexander W; Haldeman S; Sperry JL; Guyette FX; Zuckerbraun BS; Rollins-Raval MA; Raval JS; Neal MD;
    Transfusion; 2020 Jun; 60(6):1308-1318. PubMed ID: 32441353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in von Willebrand factor and ADAMTS-13 in patients following arthroplasty.
    Liu L; Ling J; Ma Z; Yuan Q; Pan J; Yang H
    Mol Med Rep; 2015 Apr; 11(4):3015-20. PubMed ID: 25482054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The ADAMTS13-VWF axis is dysregulated in chronic thromboembolic pulmonary hypertension.
    Newnham M; South K; Bleda M; Auger WR; Barberà JA; Bogaard H; Bunclark K; Cannon JE; Delcroix M; Hadinnapola C; Howard LS; Jenkins D; Mayer E; Ng C; Rhodes CJ; Screaton N; Sheares K; Simpson MA; Southwood M; Su L; Taboada D; Traylor M; Trembath RC; Villar SS; Wilkins MR; Wharton J; Gräf S; Pepke-Zaba J; Laffan M; Lane DA; Morrell NW; Toshner M
    Eur Respir J; 2019 Mar; 53(3):. PubMed ID: 30655285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased von Willebrand factor ristocetin cofactor activity and increased ADAMTS13 antigen increase postoperative drainage after coronary artery bypass grafting.
    Mazur P; Plicner D; Zdziarska J; Sadowski J; Undas A
    Eur J Cardiothorac Surg; 2014 Feb; 45(2):e26-32. PubMed ID: 24351199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Major Changes of von Willebrand Factor Multimer Distribution in Cirrhotic Patients with Stable Disease or Acute Decompensation.
    Palyu E; Harsfalvi J; Tornai T; Papp M; Udvardy M; Szekeres-Csiki K; Pataki L; Vanhoorelbeke K; Feys HB; Deckmyn H; Tornai I
    Thromb Haemost; 2018 Aug; 118(8):1397-1408. PubMed ID: 29972862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behavior of ADAMTS13 and Von Willebrand factor levels in patients after living donor liver transplantation.
    Takahashi N; Wada H; Usui M; Kobayashi T; Habe-Ito N; Matsumoto T; Uemoto S; Nobori T; Isaji S
    Thromb Res; 2013 Mar; 131(3):225-9. PubMed ID: 23266519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Genetic polymorphism of von Willebrand factor (VWF)-cleaving protease, ADAMTS13].
    Kokame K
    Brain Nerve; 2008 Nov; 60(11):1325-32. PubMed ID: 19069166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.